ApiManufacturing

India Plots a Fresh Push to Strengthen Bulk‑Drug R&D Capacity

Gujarat Themis Biosyn's Rs 1,300 Crore Coup: A Strategic Leap into Global API Dominance

The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth

India's Pharmaceutical Renaissance: How the PLI Scheme is Forging Self-Reliance in API Manufacturing

India's Pharma Power Play: Shifting Gears Towards Global API and CDMO Leadership

Unlocking India's Pharmaceutical Future: The Urgent Need for a Homegrown Drug Innovation Ecosystem

Trump's Tariff Threat: A Double-Edged Sword for India's Pharma Manufacturing Ambitions

Unlocking India's Pharmaceutical Potential: A Strategic Blueprint for Self-Reliance and Innovation

Sai Life Sciences Unleashes Massive Production Capacity at Bidar, Powering Global Drug Development

Neuland Labs Strengthens Board with Pharma Veteran Dr. Ravi Shankar Gopinath as Independent Director